Sky View Investment Advisors, LLC Gilead Sciences, Inc. Transaction History
Sky View Investment Advisors, LLC
- $698 Million
- Q2 2025
A detailed history of Sky View Investment Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sky View Investment Advisors, LLC holds 9,584 shares of GILD stock, worth $1.19 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
9,584
Previous 11,178
14.26%
Holding current value
$1.19 Million
Previous $1.25 Million
15.32%
% of portfolio
0.15%
Previous 0.19%
Shares
16 transactions
Others Institutions Holding GILD
# of Institutions
2,338Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.34 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.75 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.66 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...